Mar 23, 2021 8:00am EDT Pieris Pharmaceuticals to Host Full-Year 2020 Investor Call and Provide Corporate Update on March 30, 2021
Feb 23, 2021 8:00am EST Pieris Pharmaceuticals to Participate in the Cowen 41st Annual Health Care Conference
Nov 04, 2020 7:00am EST Pieris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Oct 28, 2020 8:00am EDT Pieris Pharmaceuticals to Host Third Quarter 2020 Investor Call and Corporate Update on November 4, 2020
Sep 20, 2020 11:00am EDT Pieris Pharmaceuticals Presents Updated Data from Phase 1 Monotherapy and Atezolizumab Combination Studies of 4-1BB/HER2 Bispecific PRS-343 at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
Aug 10, 2020 7:00am EDT Pieris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Aug 10, 2020 6:30am EDT Pieris and Lilly Enter Into a Clinical Trial Collaboration to Evaluate Combination of PRS-343 With Ramucirumab and Paclitaxel in Gastric Cancer